1380P Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.